3rd ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3).
European School of Oncology & Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
F
F
Cardoso
European School of Oncology, Milan, Italy and European School of Oncology, Bellinzona, Switzerland.
A
A
Costa
Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
E
E
Senkus
Breast Center, Genolier Cancer Center, Genolier, Switzerland.
M
M
Aapro
Department of Medical Oncology, Gustave Roussy Institute, Villejuif, France.
F
F
André
Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
C H
CH
Barrios
Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
J
J
Bergh
Department of Medical Oncology, Fortis Hospital, Kolkata, India.
G
G
Bhattacharyya
Medical Oncology Department, Hospital of Prato, Prato, Italy.
L
L
Biganzoli
Breast Unit, Champalimaud Clinical Center, Lisbon, Portugal.
M J
MJ
Cardoso
Department of Hematology and Oncology, UNC Lineberger Comprehensive Cancer Center.
L
L
Carey
METAvivor Research and Support, Annapolis, USA.
D
D
Corneliussen-James
Division of Experimental Therapeutics, European Institute of Oncology, Milan, Italy.
G
G
Curigliano
Department of Medical Oncology, Institut Curie, Paris, France.
V
V
Dieras
NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut, Beirut, Lebanon.
N
N
El Saghir
Department of Breast Tumors, Cancer Institute 'I. Chiricuta', Cluj-Napoca, Romania.
A
A
Eniu
Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
L
L
Fallowfield
Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
D
D
Fenech
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
P
P
Francis
BC Cancer Agency, Vancouver Cancer Centre, Vancouver, Canada.
K
K
Gelmon
Department of Medical Oncology, Galliera Hospital, Genoa, Italy.
A
A
Gennari
Brustzentrum der Universitat München, Munich, Germany.
N
N
Harbeck
Breast Medicine Service, Memorial Sloan-Kettering Cancer Centre, New York, USA.
C
C
Hudis
Sheba Medical Center, Tel Hashomer, Israel.
B
B
Kaufman
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston.
I
I
Krop
Advanced Breast Cancer.org, New York, USA.
M
M
Mayer
Department of Radiation Oncology, Radvoud University Medical Center, Nijmegen, The Netherlands.
H
H
Meijer
Metastatic Breast Cancer Network US, Inversness, USA.
S
S
Mertz
Breast Oncology Centre, Cancer Institute Hospital, Tokyo, Japan.
S
S
Ohno
Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
O
O
Pagani
Europa Donna, Nicosia, Cyprus.
E
E
Papadopoulos
European School of Oncology, Milan, Italy and Bellinzona, Switzerland.
F
F
Peccatori
Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
F
F
Penault-Llorca
Department of Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium.
M J
MJ
Piccart
Department of Medical Oncology, Institut Curie-Université Paris Descartes, Paris, France.
J Y
JY
Pierga
Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.
H
H
Rugo
Department of Surgery and Oncology, Johns Hopkins Breast Center, Baltimore.
L
L
Shockney
Indiana University Medical CTR, Indianapolis.
G
G
Sledge
Lombardi Comprehensive Cancer Center, Georgetown University, Washington, USA.
S
S
Swain
Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.
C
C
Thomssen
Breakthrough Breast Cancer Research Unit, King's College London and Guy's and St Thomas's NHS Foundation Trust, London, UK.
A
A
Tutt
Sandton Oncology Centre, Johannesburg, South Africa.
D
D
Vorobiof
Department of Medical Oncology, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
B
B
Xu
Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York.
L
L
Norton
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
E
E
Winer
D001943:Breast Neoplasms / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D018567:Breast Neoplasms, Male / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D064887:Observational Studies as Topic; D016032:Randomized Controlled Trials as Topic